Tumor growth was significantly inhibited after F. nucleatum inoculation in mice receiving anti-PD-L1 mAb compared to those treated only with anti-PD-L1 mAb or F. nucleatum (Fig. 2i–l). This evidence concerns the gene CD274 and neoplasm.